Orgenesis is unlocking the potential of decentralized cell and gene therapies. Developing advanced therapeutics for patients is a complex and expensive process. Orgenesis is using their POCare Platform to simplify this process. The platform, built on three components, therapies, network and technologies, is designed to overcome conventional processing challenges using automation for reliability and scalability while collaborating with hospitals and healthcare providers to create a pipeline of advanced therapies. With this approach, Orgenesis has already established a diverse pipeline portfolio with indications including immuno-oncology, viral diseases and metabolic and autoimmune diseases.

Orgenesis

Founded: 2012
Location: Germantown, MD
Employee range: 51-100
Funding: 10-100M

Short description:

Drug notes:

Long description:

Jobs: